# Refusal Is Not Robustness: Measuring Harmful Reachability in Autoregressive Language Models

Preprint · Parv Kapoor, Teresa Fortes, Claudia Mamede, Rui Abreu, Jonathan Aldrich, Eunsuk Kang

- Archive id: arxiv:2610.22754
- Published: 2026-10-15
- arXiv: https://arxiv.org/abs/2610.22754
- Source URL: https://arxiv.org/abs/2610.22754
- PDF: https://arxiv.org/pdf/2610.22754
- Provenance: arxiv

## Abstract

LLM safety evaluations via jailbreaking typically index on attack success rate (ASR): whether a generated response violates safeguards. However, ASR only evaluates sampled outputs and provides little information on the underlying generation process. Autoregressive language models define distributions over possible outputs, and a sampled refusal can coexist with substantial probability mass on harmful generation paths. We study this hidden structure through bounded continuation analysis (BCA), which models autoregressive generation as a stochastic process over token prefixes and computes the finite-horizon probability that generation reaches a harmful continuation. BCA constructs a bounded continuation tree, labels terminal continuations with a semantic harm evaluator, and estimates harmful reachability using exact probabilistic model checking. BCA complements ASR by measuring how much harmful behavior remains accessible beneath a sampled safe response. This makes it useful for distinguishing models that look identical under measured ASR values, and allocating red-team effort toward regions of the generation process with greater hidden risk. Across four instruction-tuned LLMs and 100 JailbreakBench behaviors, we show that BCA effectively quantifies hidden harmful behavior and provides a useful signal to guide red teaming.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.